Journey Medical Corp

DERM Nasdaq SEC CIK 1867066
Follow Journey Medical Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $18.9M +11.2% vs same quarter last year
Net income −$1.3M +43.2% vs same quarter last year
EPS, diluted −$0.05 +44.4% vs same quarter last year
Operating cash flow −$3.4M −44.2% vs same quarter last year
Revenue by quarter
$12.6M
$13.1M
$15M
$17M
$16.1M
$15.9M
$17.8M
$18.9M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income7 fiscal years
  • Revenue
  • Net income
−$50M$0$50M$100MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$61.2M−$11.4M
FY24$55.1M−$14.7M
FY23$59.7M−$3.9M
FY22$71M−$29.6M
FY21$63.1M−$44M
FY20$44.5M$5.3M
FY19--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−100%−50%0%50%100%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2565.8%−13.3%−18.7%
FY2462.1%−24.8%−26.6%
FY2361.6%−3.5%−6.5%
FY2256.7%−38.8%−41.7%
FY2149.2%−55.2%−69.7%
FY2067.2%17.6%11.9%
FY19---
Free cash flowOperating cash flow minus capital expenditure
−$40M−$30M−$20M−$10M$0$10MFY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25-
FY24−$24.1M
FY23$240K
FY22−$33.5M
FY21-
FY20-
FY19-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Journey Medical
  • Healthcare median
−100%−75%−50%−25%0%25%FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearJourney MedicalHealthcare median
FY25−18.7%−30.6%
FY24−26.6%−47%
FY23−6.5%−58%
FY22−41.7%−80.4%
FY21−69.7%−71.8%
FY2011.9%−62.2%
FY19-−46.2%